News

The acetylcholinesterase (AChE) program is being conducted under the agreement the company entered into with the Yissum R&D Company, the technology transfer arm of the Hebrew University of

The company said that the Canadian patent provides protection covering Javelin’s intranasal ketamine drug into 2015. Generally, Canadian ketamine patent covers the use of nasally administered ketamine to

The company said that the New York location, situated on the campus of Westchester Medical Center, will offer convenient access to specialty and traditional medications to the more

The first patient found suitable for inclusion in the Stable dissection clinical trial was a 60-year-old male diagnosed with a type B dissection of his thoracic aorta. The

Under the terms of the settlement, Palatin retains all rights to bremelanotide, its peptide in clinical development for male erectile dysfunction and female sexual dysfunction, with no obligations

The company said that the Flo-Pred (prednisolone acetate oral suspension) brand, for which there are no generic equivalents, will be sold by prescription as an anti-inflammatory agent for

The primary objective of this study comparing C2L to Sandostatin LAR was met with both C2L and Sandostatin LAR inducing a highly statistically significant decrease of insulin-like growth

The AbioCor implantable replacement heart is intended to replace the severely damaged native heart for patients who are not eligible for a transplant and have no other treatment

William Wells, CEO of ViewRay, said: “This substantial funding from blue-chip biomedical investors is a first in our industry and a testament to the promise of ViewRay’s technology